WEL Substance Profile
CAS: 14808-60-7 | Notation: Respirable fraction, carcinogen (IARC Group 1)
Current WES
0.05
mg/m³
New WEL (Dec 2026)
0.025
mg/m³
Change
-50%
reduction
Respirable crystalline silica is classified as a Group 1 carcinogen by IARC, with sufficient evidence of causing lung cancer in humans. Chronic inhalation causes silicosis, an irreversible and progressive fibrotic lung disease that reduces lung capacity and can be fatal. Accelerated silicosis develops after 5 to 15 years of moderate exposure, while acute silicosis can develop within months following very high exposure events such as dry cutting engineered stone without controls. Silica exposure is also associated with chronic obstructive pulmonary disease, kidney disease, and autoimmune conditions including scleroderma and rheumatoid arthritis. Australia's engineered stone crisis, which prompted a national ban on engineered stone benchtop fabrication from 1 July 2024, demonstrated the devastating health consequences of inadequate silica control.
Personal air sampling using a calibrated pump at 2.2 L/min with a cyclone pre-selector (Higgins-Dewell or SKC aluminium cyclone) and pre-weighed 25mm or 37mm PVC filter. Analysis by X-ray diffraction (XRD) following AS 2985 or NIOSH Method 7500. Gravimetric analysis alone is insufficient — crystalline silica must be quantified by XRD or FTIR.
EHS Atlas manages your silica worker register, tracks air monitoring results against the incoming 0.025 mg/m³ limit, and schedules health surveillance for exposed workers.
Contact Us